Cabral P D, Capurro C, Garvin J L
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA.
Facultad de Medicina, IFIBIO-HOUSSAY, UBA-CONICET, Departamento de Ciencias Fisiológicas, Ciudad Autónoma de Buenos Aires, Universidad de Buenos Aires, Buenos Aires, Argentina.
Acta Physiol (Oxf). 2015 Jul;214(3):319-28. doi: 10.1111/apha.12528. Epub 2015 Jun 1.
Medullary thick ascending limbs (mTAL) regulate Na balance and therefore blood pressure. We previously showed that cell swelling and luminal flow activates the mechanosensitive channel TRPV4 in mTAL.
We hypothesized that TRPV4 mediates flow-induced increases in intracellular Ca (Cai) in rat mTALs.
We performed ratiometric measurements of Cai in perfused mTALs.
Increasing luminal flow from 0 to 20 nL min(-1) caused Cai to peak 231 ± 29 nmol L(-1) above basal concentrations (n = 18). The general TRPV inhibitor ruthenium red at 15 and 50 μmol L(-1) reduced peak Cai by 41 ± 9 (P < 0.01; n = 5) and 77 ± 10% (P < 0.02; n = 6). The selective TRPV4 inhibitor RN1734 at 10 and 50 μmol L(-1) reduced peak Cai by 46 ± 11 (P < 0.01; n = 7) and 76 ± 5% (P < 0.02; n = 5) respectively. To specifically target TRPV4, mTALs were transduced with adenoviruses expressing TRPV4 small hairpin (sh) RNA. In non-transduced control mTALs, luminal flow generated a peak increase in Cai of 111 ± 21 nmol L(-1) (n = 8). In TRPV4shRNA-transduced mTALs, the Cai peak was reduced to 56 ± 8 nmol L(-1) (P < 0.03, n = 9). Removing extracellular Ca completely abolished flow-induced increases in Cai. Increasing luminal flow in the presence of hexokinase 20 (U mL(-1) ) to scavenge extracellular ATP did not modify significantly the increases in Cai induced by luminal flow. Finally, we studied the effect of the TRPV4 selective agonist GSK1016790A on Cai. In the absence of luminal flow, GSK1016790A (10 nmol L(-1) ) increased Cai from 60 ± 11 nmol L(-1) to 262 ± 71 nmol L(-1) (P < 0.05; n = 7).
We conclude that flow-induced increases in Cai are mediated primarily by TRPV4 in the rat mTAL.
髓袢升支粗段(mTAL)调节钠平衡,进而调节血压。我们之前表明,细胞肿胀和管腔液流可激活mTAL中的机械敏感通道TRPV4。
我们假设TRPV4介导大鼠mTAL中液流诱导的细胞内钙(Cai)增加。
我们对灌注的mTAL进行了Cai的比率测量。
将管腔液流从0增加到20 nL min⁻¹,导致Cai在基础浓度之上达到峰值231±29 nmol L⁻¹(n = 18)。15和50 μmol L⁻¹的通用TRPV抑制剂钌红分别使Cai峰值降低41±9%(P < 0.01;n = 5)和77±10%(P < 0.02;n = 6)。10和50 μmol L⁻¹的选择性TRPV4抑制剂RN1734分别使Cai峰值降低46±11%(P < 0.01;n = 7)和76±5%(P < 0.02;n = 5)。为了特异性靶向TRPV4,用表达TRPV4小发夹(sh)RNA的腺病毒转导mTAL。在未转导的对照mTAL中,管腔液流使Cai峰值增加111±21 nmol L⁻¹(n = 8)。在转导了TRPV4 shRNA的mTAL中,Cai峰值降至56±8 nmol L⁻¹(P < 0.03,n = 9)。去除细胞外钙完全消除了液流诱导的Cai增加。在存在己糖激酶20(U mL⁻¹)以清除细胞外ATP的情况下增加管腔液流,并未显著改变管腔液流诱导的Cai增加。最后,我们研究了TRPV4选择性激动剂GSK1016790A对Cai的影响。在无管腔液流的情况下,GSK1016790A(10 nmol L⁻¹)使Cai从60±11 nmol L⁻¹增加到262±71 nmol L⁻¹(P < 0.05;n = 7)。
我们得出结论,大鼠mTAL中液流诱导的Cai增加主要由TRPV4介导。